Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden-Reference-Cited by-同舟云学术

Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden

Published:2024-08-22 Issue:8 Volume:144 Page:914-917
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Chrisman Lauren P.¹^ORCID,Trimark Payton Fors²^ORCID,Pang Yanzhen¹^ORCID,Pease David Randall¹^ORCID,Martinez-Escala Maria Estela¹^ORCID,Nguyen William Q.¹^ORCID,Fernandez Rony¹,Griffin Teresa L.¹,Ayanruoh Lindsey¹,Hooper Madeline J.¹^ORCID,Zhou Xiaolong A.¹^ORCID,Fu Lucy²,Wolniak Kristy L.²^ORCID,Guitart Joan¹^ORCID

Affiliation:

1. 1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL

2. 2Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL

Abstract

Comparison of the 2007 EORTC/ISCL and the 2022 EORTC/ISCL/USCLC blood staging guidelines for cutaneous T-cell lymphoma at a single institution reveals the newer guidelines fail to detect a subset of patients with Sézary syndrome with low blood burden.

Publisher

American Society of Hematology

Link

https://ashpublications.org/blood/article-pdf/144/8/914/2238675/blood_bld-2023-023584-main.pdf

Reference10 articles.

1. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma;Scarisbrick;Blood,2001

2. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression;Kim;Arch Dermatol,2003

3. WHO-EORTC classification for cutaneous lymphomas;Willemze;Blood,2005

4. Early clinical manifestations of Sézary syndrome: a multicenter retrospective cohort study;Mangold;J Am Acad Dermatol,2017

5. Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity;Park;Blood,2021